Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Sulfatide is required for efficient replication of influenza A virus.

Takahashi T, Murakami K, Nagakura M, Kishita H, Watanabe S, Honke K, Ogura K, Tai T, Kawasaki K, Miyamoto D, Hidari KI, Guo CT, Suzuki Y, Suzuki T.

J Virol. 2008 Jun;82(12):5940-50. doi: 10.1128/JVI.02496-07. Epub 2008 Apr 16.

2.

Sulfatide regulates caspase-3-independent apoptosis of influenza A virus through viral PB1-F2 protein.

Takahashi T, Takaguchi M, Kawakami T, Suzuki T.

PLoS One. 2013 Apr 4;8(4):e61092. doi: 10.1371/journal.pone.0061092. Print 2013.

3.

Binding kinetics of sulfatide with influenza A virus hemagglutinin.

Takahashi T, Kawagishi S, Masuda M, Suzuki T.

Glycoconj J. 2013 Oct;30(7):709-16. doi: 10.1007/s10719-013-9477-7. Epub 2013 Apr 21.

PMID:
23604989
4.

Role of sulfatide in influenza A virus replication.

Takahashi T, Suzuki T.

Biol Pharm Bull. 2015;38(6):809-16. doi: 10.1248/bpb.b15-00119. Review.

5.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

6.

Heat shock protein 70 inhibits the activity of Influenza A virus ribonucleoprotein and blocks the replication of virus in vitro and in vivo.

Li G, Zhang J, Tong X, Liu W, Ye X.

PLoS One. 2011 Feb 24;6(2):e16546. doi: 10.1371/journal.pone.0016546.

7.

Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation.

Sharma K, Tripathi S, Ranjan P, Kumar P, Garten R, Deyde V, Katz JM, Cox NJ, Lal RB, Sambhara S, Lal SK.

PLoS One. 2011;6(6):e20215. doi: 10.1371/journal.pone.0020215. Epub 2011 Jun 15.

8.

Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.

Betts RJ, Mann TS, Henry PJ.

J Pharmacol Exp Ther. 2012 Dec;343(3):725-35. doi: 10.1124/jpet.112.196485. Epub 2012 Sep 17.

9.

Binding of sulphatide to recombinant haemagglutinin of influenza A virus produced by a baculovirus protein expression system.

Takahashi T, Satoh H, Takaguchi M, Takafuji S, Yokoyama H, Fujii S, Suzuki T.

J Biochem. 2010 Apr;147(4):459-62. doi: 10.1093/jb/mvq013. Epub 2010 Feb 9.

PMID:
20145020
10.

Role of sulfatide in normal and pathological cells and tissues.

Takahashi T, Suzuki T.

J Lipid Res. 2012 Aug;53(8):1437-50. doi: 10.1194/jlr.R026682. Epub 2012 May 22. Review.

11.

Sulfatide negatively regulates the fusion process of human parainfluenza virus type 3.

Takahashi T, Ito K, Fukushima K, Takaguchi M, Hayakawa T, Suzuki Y, Suzuki T.

J Biochem. 2012 Oct;152(4):373-80. Epub 2012 Jul 20.

PMID:
22821828
12.

Influenza A viral nucleoprotein interacts with cytoskeleton scaffolding protein α-actinin-4 for viral replication.

Sharma S, Mayank AK, Nailwal H, Tripathi S, Patel JR, Bowzard JB, Gaur P, Donis RO, Katz JM, Cox NJ, Lal RB, Farooqi H, Sambhara S, Lal SK.

FEBS J. 2014 Jul;281(13):2899-914. doi: 10.1111/febs.12828. Epub 2014 Jun 2.

13.

Functional analysis of glyco-molecules that bind with influenza virus.

Takahashi T.

Uirusu. 2016;66(1):101-116. doi: 10.2222/jsv.66.101. Review.

14.

[Role of sulfatide on influenza A virus replication].

Suzuki T, Takahashi T, Suzuki Y.

Tanpakushitsu Kakusan Koso. 2008 Sep;53(12 Suppl):1676-82. Review. Japanese. No abstract available.

PMID:
21089387
15.

[Function of glycochains in virus infection].

Takahashi T.

Yakugaku Zasshi. 2014;134(8):889-99. Japanese.

16.

Cross-protective effect of antisense oligonucleotide developed against the common 3' NCR of influenza A virus genome.

Kumar P, Kumar B, Rajput R, Saxena L, Banerjea AC, Khanna M.

Mol Biotechnol. 2013 Nov;55(3):203-11. doi: 10.1007/s12033-013-9670-8.

PMID:
23729285
17.

Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine.

Anhlan D, Hrincius ER, Scholtissek C, Ludwig S.

Vaccine. 2012 Jun 22;30(30):4480-9. doi: 10.1016/j.vaccine.2012.04.070. Epub 2012 May 7.

PMID:
22575164
18.

Glucosyl hesperidin prevents influenza a virus replication in vitro by inhibition of viral sialidase.

Saha RK, Takahashi T, Suzuki T.

Biol Pharm Bull. 2009 Jul;32(7):1188-92.

19.

Nucleoprotein of influenza A virus negatively impacts antiapoptotic protein API5 to enhance E2F1-dependent apoptosis and virus replication.

Mayank AK, Sharma S, Nailwal H, Lal SK.

Cell Death Dis. 2015 Dec 17;6:e2018. doi: 10.1038/cddis.2015.360.

20.

Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase.

LeBouder F, Lina B, Rimmelzwaan GF, Riteau B.

J Gen Virol. 2010 Nov;91(Pt 11):2753-61. doi: 10.1099/vir.0.023804-0. Epub 2010 Aug 11.

PMID:
20702651

Supplemental Content

Support Center